Hydrocortisone

氢化可的松

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameHydrocortisone
Drug Alias NameHidrocortisona氢化可体松Cortisol氢化考的松Hydrocortisone extended release +[24
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsUlcerative proctitisCoronavirus Disease 2019 (COVID-19)Phobic Disorders +[108
Global Approved IndicationsAnaphylaxisHypersensitivityHypoadrenocorticism, Familial +[8
Approved Indications in ChinaAnaphylaxisHypoadrenocorticism, FamilialInfections
Original Approved Country/TerritoryUnited States
Original Approved Date1952/08/05
Country/TerritoryCanadaUnited StatesVietnam +[22
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active IndicationsUlcerative proctitisCoronavirus Disease 2019 (COVID-19)Memory, Long-Term +[94
Inactive IndicationsPhobic DisordersDepressionWhiplash Injuries +[14

Other Information

ATC CodeA01AC03A07EA02C05AA01 +[9